Chim C. Lang

1992–2025 年に発表

164
論文数
21,078
被引用数
82
h 指数
159
i10 指数

被引用数

Chim C. Lang の年別被引用数1972 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 11 件1995 年: 被引用 4 件1996 年: 被引用 32 件1997 年: 被引用 27 件1998 年: 被引用 45 件1999 年: 被引用 35 件2000 年: 被引用 42 件2001 年: 被引用 47 件2002 年: 被引用 52 件2003 年: 被引用 36 件2004 年: 被引用 80 件2005 年: 被引用 46 件2006 年: 被引用 80 件2007 年: 被引用 103 件2008 年: 被引用 91 件2009 年: 被引用 117 件2010 年: 被引用 93 件2011 年: 被引用 111 件2012 年: 被引用 97 件2013 年: 被引用 130 件2014 年: 被引用 116 件2015 年: 被引用 117 件2016 年: 被引用 108 件2017 年: 被引用 118 件2018 年: 被引用 115 件2019 年: 被引用 475 件2020 年: 被引用 782 件2021 年: 被引用 798 件2022 年: 被引用 650 件2023 年: 被引用 529 件2024 年: 被引用 876 件2025 年: 被引用 506 件2026 年: 被引用 21 件1973〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,068 件、この内訳の 16.9%イギリス: 引用元論文 1,244 件、この内訳の 10.2%中国: 引用元論文 787 件、この内訳の 6.4%イタリア: 引用元論文 718 件、この内訳の 5.9%ドイツ: 引用元論文 659 件、この内訳の 5.4%オランダ: 引用元論文 571 件、この内訳の 4.7%カナダ: 引用元論文 568 件、この内訳の 4.6%フランス: 引用元論文 397 件、この内訳の 3.2%スウェーデン: 引用元論文 344 件、この内訳の 2.8%スペイン: 引用元論文 321 件、この内訳の 2.6%オーストラリア: 引用元論文 313 件、この内訳の 2.6%ギリシャ: 引用元論文 263 件、この内訳の 2.1%
0%16.9%その他 32.6%

分野

  • Medicine83.1%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Immunology and Microbiology1.6%
  • Nursing1.4%
  • Neuroscience1.1%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • その他3.1%

トピック

  • Heart Failure Treatment and Management7.9%
  • Cardiovascular Function and Risk Factors7.1%
  • Diabetes Treatment and Management3.7%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2%
  • Metabolism, Diabetes, and Cancer1.9%
  • Cardiovascular Disease and Adiposity1.5%
  • その他75.9%

共著者

全論文

検索で開く
  1. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul W X Foley, Fraser J Graham, Alan G. Japp, Rebecca Lane, Ninian N. Lang, Andrew Ludman, Iain C. Macdougall, Pierpaolo Pellicori, Robin Ray, Michele Robertson, Alison Seed, Ian Ford, Nicholas A. Boon, Shannon Amoils, Callum Chapman, Thomas G Diness, John McMurray, Richard Mindham, Pamela Sandu, Claes Christian Strom, Maureen Travers, Robert Wilcox, Allan D. Struthers, Patrick B. Mark, Christopher J. Weir, Elena Cowan, Charlotte Turner, Rosalynn Austin, Paula Rogers, Badri Chandrasekaran, E Fraile, Lynsey Kyeremeh, Lorraine McGregor, Joanna Osmanska, Barbara Meyer, Faheem Ahmad, Jude Fisher, Christina Summersgill, Katarzyna Adeniji, Rajkumar Chinnadurai, Lisa Massimo, Clare S. Hardman, Daisy Sykes, Sarah Frank, Simon Smith, Mohamed Anwar, Beth Whittington, Vennessa Sookhoo, Sinéad Lyons, Janet Middle, Kay Housley, Andrew L. Clark, Jeanne Bulemfu, Christopher Critoph, Victor Chong, Stephen J. Wood, Benjamin R. Szwejkowski, Chim C. Lang, Jackie Duff, Susan M. MacDonald, Rebekah Schiff, Patrick Donnelly, Thuraia Nageh, Swapna Kunhunny, Roy S. Gardner, Marion McAdam, Elizabeth McPherson, Prithwish Banerjee, Eleanor Sear, Nigel Edwards ほか 91 名 - The Lancet 2022 被引用: 372

  2. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Devendra K Agarwal, Maher Agha, Azazuddin Ahmed, Petteri Ahtiainen, Elmar Aigner, Naik Ajay, Norsiah Ali, Amer Al-Karadsheh, Roy Allison, Dale C Allison, Diana Alpenidze, Yuksel Altuntas, Ayham Al-Zoebi, Roy Ambuj, John Amerena, Robert J Anderson, Toshiaki Ando, Robert Andrews, Elizaveta Antonova, Karl-Friedrich Appel, Flávia B Arantes, Mustafa Araz, Yaron Arbel, José L Arenas León, Georgia Argyrakopoulou, Mehrdad Ariani, Maria A Arias Mendoza, Ahmed A Arif, Jaspal Arneja, Vanita R Aroda, Louis J Aronne, Margaret Arstall, Njaimeh Asamoah, Milika Asanin, Hanid Audish, Rodica Avram, Aysha Badat, Corin V Badiu, Wa'el Bakdash, Okan S Bakiner, Vuyokazi N Bandezi, Liew H Bang, Sandeep Bansal, Marietta Baranyai, Olga Barbarash, Mark Barber, Otis Barnum, Gilles Barone Rochette, Amir Bashkin, Seth Baum, Harold E Bays, Alberto E Bazzoni Ruiz, Maciej Beckowski, Yaswin Beerachee, Srikanth Bellary, Lidia Belousova, Martin Berk, Marc Bernstein, Cesare Berra, Isaac Beshay, Ajit Bhagwat, Arti Bhan, William C Biggs, Liana Billings, Fahed Bitar, Bradley Block, Simona Bo, Pawel Bogdanski, Olga O Bolshakova, Alla A Boshchenko ほか 732 名 - The Lancet 2024 被引用: 230

  3. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status

    著者: , , , , , , , , , , , , , , , - Circulation Research 2016 被引用: 721

  4. The Clinical Significance of Interleukin-6 in Heart Failure: Results from the BIOSTAT-CHF Study

    著者: , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2019 被引用: 281

  5. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study

    著者: , , , , , , , , , , , , , , - The Lancet 2005 被引用: 2,897

  6. Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction

    著者: , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2018 被引用: 306

  7. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial

    著者: , , , , , , , , , , , , , , , , - The Lancet 2022 被引用: 216

  8. A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial

    著者: , , , , , - European Heart Journal 2020 被引用: 256

  9. Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eugenio B Reyes, Bambang Budi Siswanto, Wataru Shimizu, Shu Zhang, Adriaan A. Voors - The Lancet 2019 被引用: 247

  10. Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study

    著者: , , , , , , , , , , , , , , , , - European Heart Journal 2017 被引用: 403

  11. Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure

    著者: , , , , , - Circulation 2020 被引用: 251

  12. Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Myocardial Fibrosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandeep S Hothi, Nicholas A. Boon, Sanjay Prasad, Niall Keenan, Dana Dawson, Thomas A. Treibel, Manish Motwani, Christopher A. Miller, Nicholas L. Mills, Ronak Rajani, David P Ripley, Gerry P McCann, Bernard Prendergast, Anvesha Singh, David E. Newby, Marc R. Dweck, EVOLVED investigators, Kush Patel, Mervyn Andiapen, Lucinda Wynne, Hunaid A. Vohra, Jodie Hussain, Kelly Patel, Stephen Dorman, Laura Gallego‐Yerga, Jonaifah Ramirez, Emily Redman, Sofia Matia, Madelaine Ocampo, Annaliza Sevilliano, Gracie Maloney, Amanda Solesbury, Steven Church, Lauren Kittridge, Jovita Rebong, Jacqueline Colnet, Johannes Pintacasi, James H. Morrissey, Aoife Tipping, Stephanie Hunt, Amy Raynsford, Daniel L. Cooke, Dan Sado, Jonathan Byrne, Abigail Knighton, Jonathan Breeze, Michail Sionas, J. Crawford Crowe, Maju Jose, Thabitha Charles, Anu Mary Oommen, Victoria Clegg, April Edwards, Adele Trueman, Rajeev Padjama, Suzanne Higson, Martin Sherwood, Sarah Mackie, Anita McNab, Preetha Mathew, Akhila Muthuswamy, Sujata Blane, Sheetal Crasta, Kathryn Walker, Anne Ankers, Philip McGrouther, Dean J. Miller, Denise O'Donell, Melanie Tolson, Anne Firor Scott ほか 86 名 - JAMA 2024 被引用: 123

  13. Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes

    著者: , , , , , , , , - Journal of the American College of Cardiology 2019 被引用: 222

  14. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction

    著者: , , , , , , , , , , , , , , , - European Journal of Heart Failure 2021 被引用: 145

  15. Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial

    著者: , , , , , , , , , , , , , - Diabetes Care 2020 被引用: 201

  16. Pathophysiologic Processes and Novel Biomarkers Associated With Congestion in Heart Failure

    著者: , , , , , , , , , , , - JACC Heart Failure 2022 被引用: 76

  17. Clinical Role of CA125 in Worsening Heart Failure

    著者: , , , , , , , , , , , , , , - JACC Heart Failure 2020 被引用: 113

  18. Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients with New-Onset or Worsening Heart Failure with Reduced and Preserved Ejection Fraction

    著者: , , , , , , , , , , , , , , , , - ESC Heart Failure 2021 被引用: 89

  19. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction

    著者: , , , , , , , , , , , , , , , , , - International Journal of Cardiology 2018 被引用: 203

  20. Insulin-Like Growth Factor Binding Protein 7 (IGFBP7), a Link Between Heart Failure and Senescence

    著者: , , , , , , , , , , , , , , , , , , , , - ESC Heart Failure 2022 被引用: 53

  21. A Systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: Rationale, Design, and Baseline Characteristics of BIOSTAT-CHF

    著者: , , , , , , , , , , , , , , , - European Journal of Heart Failure 2016 被引用: 204

  22. Repurposing Metformin for Cardiovascular Disease

    著者: , - Circulation 2018 被引用: 148

  23. Pulmonary Arterial Hypertension: Pathophysiology and Treatment

    著者: , , , - Diseases 2018 被引用: 178

  24. Selenium and Outcome in Heart Failure

    著者: , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2019 被引用: 151